Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Design, synthesis and biological evaluation of a bi-specific vaccine against α-pyrrolidinovalerophenone (α-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats.

McClenahan SJ, Kormos CM, Gunnell M, Hambuchen MD, Lamb P, Carroll FI, Lewin AH, Peterson EC, Owens SM.

Vaccine. 2019 Oct 16. pii: S0264-410X(19)31371-4. doi: 10.1016/j.vaccine.2019.10.008. [Epub ahead of print]

PMID:
31629568
2.

Antibody production and pharmacokinetics of METH in rats following vaccination with the METH vaccine, IXT-v100, adjuvanted with GLA-SE.

Stevens MW, Rüedi-Bettschen D, Gunnell MG, Tawney R, West CM, Owens SM.

Drug Alcohol Depend. 2019 Nov 1;204:107484. doi: 10.1016/j.drugalcdep.2019.05.016. Epub 2019 Aug 30.

PMID:
31521953
3.

Effect of Bile Duct Ligation-induced Liver Dysfunction on Methamphetamine Pharmacokinetics and Locomotor Activity in Rats.

Hambuchen MD, Berquist MD, Simecka CM, McGill MR, Gunnell MG, Hendrickson HP, Owens SM.

J Pharm Pharm Sci. 2019;22(1):301-312. doi: 10.18433/jpps30471.

4.

Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats.

McClenahan SJ, Hambuchen MD, Simecka CM, Gunnell MG, Berquist MD, Owens SM.

Drug Alcohol Depend. 2019 Feb 1;195:140-147. doi: 10.1016/j.drugalcdep.2018.12.006. Epub 2019 Jan 4.

PMID:
30634109
5.

Community Resilience, Psychological Resilience, and Depressive Symptoms: An Examination of the Mississippi Gulf Coast 10 Years After Hurricane Katrina and 5 Years After the Deepwater Horizon Oil Spill.

Lee J, Blackmon BJ, Cochran DM, Kar B, Rehner TA, Gunnell MS.

Disaster Med Public Health Prep. 2018 Apr;12(2):241-248. doi: 10.1017/dmp.2017.61. Epub 2017 Aug 30.

PMID:
28851469
6.

The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats.

Hambuchen MD, Hendrickson HP, Gunnell MG, McClenahan SJ, Ewing LE, Gibson DM, Berquist MD, Owens SM.

Drug Alcohol Depend. 2017 Oct 1;179:347-354. doi: 10.1016/j.drugalcdep.2017.07.011. Epub 2017 Aug 8.

7.

Natural Selection in Virulence Genes of Francisella tularensis.

Gunnell MK, Robison RA, Adams BJ.

J Mol Evol. 2016 Jun;82(6):264-78. doi: 10.1007/s00239-016-9743-y. Epub 2016 May 13.

PMID:
27177502
8.

Chronic treatment of (+)-methamphetamine-induced locomotor effects in rats using one or a combination of two high affinity anti-methamphetamine monoclonal antibodies.

Hambuchen MD, Rüedi-Bettschen D, Gunnell MG, Hendrickson H, Owens SM.

Hum Vaccin Immunother. 2016 Sep;12(9):2240-8. doi: 10.1080/21645515.2016.1179407. Epub 2016 May 10.

9.

Optimization of a methamphetamine conjugate vaccine for antibody production in mice.

Stevens MW, Gunnell MG, Tawney R, Owens SM.

Int Immunopharmacol. 2016 Jun;35:137-141. doi: 10.1016/j.intimp.2016.03.028. Epub 2016 Apr 16.

10.

The Genetic Diversity and Evolution of Francisella tularensis with Comments on Detection by PCR.

Gunnell MK, Adams BJ, Robison RA.

Curr Issues Mol Biol. 2016;18:79-91. Epub 2015 Sep 3. Review.

11.

Simple radiometric method for accurately quantitating epitope densities of hapten-protein conjugates with sulfhydryl linkages.

Peterson EC, Hambuchen MD, Tawney RL, Gunnell MG, Cowell JL, Lay JO Jr, Blough BE, Carroll FI, Owens SM.

Bioconjug Chem. 2014 Dec 17;25(12):2112-5. doi: 10.1021/bc500456z. Epub 2014 Dec 4.

12.

Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food.

Rüedi-Bettschen D, Wood SL, Gunnell MG, West CM, Pidaparthi RR, Carroll FI, Blough BE, Owens SM.

Vaccine. 2013 Sep 23;31(41):4596-602. doi: 10.1016/j.vaccine.2013.07.038. Epub 2013 Jul 29.

13.

A multiplex real-time PCR assay for the detection and differentiation of Francisella tularensis subspecies.

Gunnell MK, Lovelace CD, Satterfield BA, Moore EA, O'Neill KL, Robison RA.

J Med Microbiol. 2012 Nov;61(Pt 11):1525-31. doi: 10.1099/jmm.0.046631-0. Epub 2012 Aug 2.

PMID:
22859584
14.

Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines.

Carroll FI, Blough BE, Pidaparthi RR, Abraham P, Gong PK, Deng L, Huang X, Gunnell M, Lay JO Jr, Peterson EC, Owens SM.

J Med Chem. 2011 Jul 28;54(14):5221-8. doi: 10.1021/jm2004943. Epub 2011 Jun 29.

15.

The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse.

Carroll FI, Abraham P, Gong PK, Pidaparthi RR, Blough BE, Che Y, Hampton A, Gunnell M, Lay JO Jr, Peterson EC, Owens SM.

J Med Chem. 2009 Nov 26;52(22):7301-9. doi: 10.1021/jm901134w.

16.

Engineering and characterization of a mouse/human chimeric anti-phencyclidine monoclonal antibody.

Lacy HM, Gunnell MG, Laurenzana EM, Owens SM.

Int Immunopharmacol. 2008 Jan;8(1):1-11. Epub 2007 Oct 23.

17.

Using hapten design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse.

Peterson EC, Gunnell M, Che Y, Goforth RL, Carroll FI, Henry R, Liu H, Owens SM.

J Pharmacol Exp Ther. 2007 Jul;322(1):30-9. Epub 2007 Apr 23.

PMID:
17452421
18.

Effects of anti-phencyclidine and anti-(+)-methamphetamine monoclonal antibodies alone and in combination on the discrimination of phencyclidine and (+)-methamphetamine by pigeons.

Daniels JR, Wessinger WD, Hardwick WC, Li M, Gunnell MG, Hall CJ, Owens SM, McMillan DE.

Psychopharmacology (Berl). 2006 Mar;185(1):36-44. Epub 2006 Feb 15.

PMID:
16479372
19.

Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat.

McMillan DE, Hardwick WC, Li M, Gunnell MG, Carroll FI, Abraham P, Owens SM.

J Pharmacol Exp Ther. 2004 Jun;309(3):1248-55. Epub 2004 Mar 1.

PMID:
14993256
20.

Treatment of adverse effects of excessive phencyclidine exposure in rats with a minimal dose of monoclonal antibody.

Laurenzana EM, Gunnell MG, Gentry WB, Owens SM.

J Pharmacol Exp Ther. 2003 Sep;306(3):1092-8. Epub 2003 Jun 26.

PMID:
12829731
21.

Sexual dimorphism in phencyclidine in vitro metabolism and pharmacokinetics in rats.

Shelnutt SR, Gunnell M, Owens SM.

J Pharmacol Exp Ther. 1999 Sep;290(3):1292-8.

PMID:
10454506
22.

Dose- and time-dependent changes in phencyclidine metabolite covalent binding in rats and the possible role of CYP2D1.

Owens SM, Gunnell M, Laurenzana EM, Valentine JL.

J Pharmacol Exp Ther. 1993 Jun;265(3):1261-6.

PMID:
8510006
23.

Genomic dispersal of the ets gene family during metazoan evolution.

Lautenberger JA, Burdett LA, Gunnell MA, Qi S, Watson DK, O'Brien SJ, Papas TS.

Oncogene. 1992 Sep;7(9):1713-9.

PMID:
1501883
24.

Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.

Owens SM, Zorbas M, Lattin DL, Gunnell M, Polk M.

J Pharmacol Exp Ther. 1988 Aug;246(2):472-8.

PMID:
2457075
25.

The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus.

Beck TW, Huleihel M, Gunnell M, Bonner TI, Rapp UR.

Nucleic Acids Res. 1987 Jan 26;15(2):595-609.

26.

Characterization of murine A-raf, a new oncogene related to the v-raf oncogene.

Huleihel M, Goldsborough M, Cleveland J, Gunnell M, Bonner T, Rapp UR.

Mol Cell Biol. 1986 Jul;6(7):2655-62.

27.

The complete coding sequence of the human raf oncogene and the corresponding structure of the c-raf-1 gene.

Bonner TI, Oppermann H, Seeburg P, Kerby SB, Gunnell MA, Young AC, Rapp UR.

Nucleic Acids Res. 1986 Jan 24;14(2):1009-15.

28.

Structure and biological activity of human homologs of the raf/mil oncogene.

Bonner TI, Kerby SB, Sutrave P, Gunnell MA, Mark G, Rapp UR.

Mol Cell Biol. 1985 Jun;5(6):1400-7.

29.

A new oncogene, c-raf, is located on mouse chromosome 6.

Kozak C, Gunnell MA, Rapp UR.

J Virol. 1984 Jan;49(1):297-9.

31.

Normal mouse serum contains peptides which induce fibroblasts to grow in soft agar.

Rapp UR, Gunnell M, Marquardt H.

J Cell Biochem. 1983;21(1):29-38.

PMID:
6603462
32.

Reduced uptake and incorporation of 3H-thymidine in Fanconi anemia fibroblasts.

Shoyab M, Gunnell M, Lubiniecki AS.

Hum Genet. 1981;57(3):296-9.

PMID:
7250972
33.

T-antigen expression in human skin fibroblasts is not regulated by an endogenous interferon response to SV40 infection.

Lubiniecki AS, Blattner WA, Cruttenden V, Gunnell M, Tarr GC, Fraumeni JF Jr.

Arch Virol. 1978;57(4):349-54.

PMID:
210745
34.

Systematic variables affecting simian virus 40-induced T-antigen expression and transformation in human cells.

Kaplan MM, Lubiniecki AS, Blattner WA, Mason T, Giard DJ, Gunnell M, Triantafellu N, Fraumeni JF Jr.

J Clin Microbiol. 1976 Jun;3(6):593-8.

Supplemental Content

Loading ...
Support Center